Figure 4.
(A) Cumulative incidence of progression to acute myeloid leukemia in the three groups of patients. (B) Cumulative incidence of progression to acute myeloid leukemia in CMML and MDS with SF3B1 mutation.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.